Frequencies of thiopurine S-methyltransferase mutant alleles (TPMT*2, *3A, *3B and *3C) in 151 healthy Japanese subjects and the inheritance of TPMT*3C in the family of a propositus

被引:62
作者
Kubota, T
Chiba, K
机构
[1] Chiba Univ, Fac Pharmaceut Sci, Lab Biochem Pharmacol & Toxicol, Inage Ku, Chiba, Japan
[2] SRL Inc, Res Testing Dept, Hachioji, Tokyo, Japan
关键词
genotype; Japanese; TPMT*3C;
D O I
10.1046/j.1365-2125.2001.01371.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aims To determine the frequencies of four thiopurine S-methyltransferase (TPMT) mutant alleles, TPMT(star)2, (star)3A, (star)3B and (star)3C in a normal Japanese population. Methods Genotypes were determined in 151 Japanese subjects and in six family members of a propositus using polymerase chain reaction (PCR)-restriction fragment length polymorphism and allele-specific PCR assays. Results Only one TPMT(star)3C heterozygote was identified (gene frequency 0.3%). TPMT(star)2, (star)3A and (star)3B were not detected. In addition, TPMT(star)3C was found to have been inherited from the mother and passed on to the son of the propositus. Conclusions (TPMTC)-C-star3 appears to be most prevalent among the known mutant allele of TPMT in a Japanese population which may have some relevance for the treatment of Japanese patients with thiopurine drugs.
引用
收藏
页码:475 / 477
页数:3
相关论文
共 17 条
[11]   THIOPURINE METHYLTRANSFERASE ACTIVITY IN AMERICAN WHITE SUBJECTS AND BLACK SUBJECTS [J].
MCLEOD, HL ;
LIN, JS ;
SCOTT, EP ;
PUI, CH ;
EVANS, WE .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (01) :15-20
[12]   Human thiopurine methyltransferase pharmacogenetics: Gene sequence polymorphisms [J].
Otterness, D ;
Szumlanski, C ;
Lennard, L ;
Klemetsdal, B ;
Aarbakke, J ;
ParkHah, JO ;
Iven, H ;
Schmiegelow, K ;
Branum, E ;
OBrien, J ;
Weinshilboum, R .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 62 (01) :60-73
[13]   Human thiopurine methyltransferase pharmacogenetics - Kindred with a terminal exon splice junction mutation that results in loss of activity [J].
Otterness, DM ;
Szumlanski, CL ;
Wood, TC ;
Weinshilboum, RM .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (05) :1036-1044
[14]   AZATHIOPRINE-INDUCED MYELOSUPPRESSION IN THIOPURINE METHYLTRANSFERASE DEFICIENT HEART-TRANSPLANT RECIPIENT [J].
SCHUTZ, E ;
GUMMERT, J ;
MOHR, F ;
OELLERICH, M .
LANCET, 1993, 341 (8842) :436-436
[15]  
Tai HL, 1996, AM J HUM GENET, V58, P694
[16]   Enhanced proteolysis of thiopurine S-methyltransferase (TPMT) encoded by mutant alleles in humans (TPMT*3A, TPMT*2): Mechanisms for the genetic polymorphism of TPMT activity [J].
Tai, HL ;
Krynetski, EY ;
Schuetz, EG ;
Yanishevski, Y ;
Evans, WE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (12) :6444-6449
[17]   Molecular diagnosis of thiopurine S-methyltransferase deficiency: Genetic basis for azathioprine and mercaptopurine intolerance [J].
Yates, CR ;
Krynetski, EY ;
Loennechen, T ;
Fessing, MY ;
Tai, HL ;
Pui, CH ;
Relling, MV ;
Evans, WE .
ANNALS OF INTERNAL MEDICINE, 1997, 126 (08) :608-+